4//SEC Filing
LAWRENCE DAVID 4
Accession 0001209191-19-058937
CIK 0001008848other
Filed
Dec 3, 7:00 PM ET
Accepted
Dec 4, 7:49 AM ET
Size
5.1 KB
Accession
0001209191-19-058937
Insider Transaction Report
Form 4
LAWRENCE DAVID
Chief Financial Officer
Transactions
- Sale
Common Stock
2019-12-02$1.60/sh−1,176$1,880→ 12,961 total
Footnotes (2)
- [F1]Sales pursuant to a 10b5-1 plan. These sales are primarily intended to cover the tax liability resulting from restricted stock vesting.
- [F2]The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $1.53 to $1.68 per share. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
Documents
Issuer
ACORDA THERAPEUTICS INC
CIK 0001008848
Entity typeother
Related Parties
1- filerCIK 0001272353
Filing Metadata
- Form type
- 4
- Filed
- Dec 3, 7:00 PM ET
- Accepted
- Dec 4, 7:49 AM ET
- Size
- 5.1 KB